Building Compliance Infrastructure for Regulated AI — Goodly Develops AI-QMS

The European Union's AI Act is not a future obligation — it is becoming binding now. Any organization that develops, deploys, or markets artificial intelligence systems affecting regulated industries — healthcare, pharmaceuticals, financial services — faces new compliance requirements that existing quality management frameworks were never designed to handle.

Goodly Technologies is developing AI-QMS: a lean, modular compliance platform purpose-built for exactly this challenge. We provide governance as a business booster not a bureaucratic obstacle.

The Compliance Gap No One Is Solving Well

The EU AI Act introduces risk-based classification, mandatory conformity assessments, transparency requirements, and post-market monitoring obligations for AI systems. At the same time, sector-specific frameworks — ISO 13485 for medical devices, GAMP 5 for pharma, ISO 42001 for AI management — must be satisfied in parallel.

Legacy quality management systems were built for hardware and software in a pre-AI era. They are not equipped for the velocity, opacity, and adaptability of modern AI systems and they are usually aimed at larger corporations, a fact that is reflected in the cost. The result is a growing compliance gap that will be measured in regulatory findings, audit failures, and delayed approvals.

What AI-QMS Does

AI-QMS is a compliance management platform for companies building or deploying AI  — particularly in regulated industries like medtech, pharma and healthcare.  

Instead of managing ISO standards, EU regulations, and internal quality processes across spreadsheets and shared drives, teams get one central system. It covers the full compliance lifecycle: registering AI systems, running risk assessments, generating and approving documentation, and demonstrating conformity to regulators — all with a complete audit trail.  What sets it apart is how it connects compliance to the people responsible for it. Built-in training management ensures every team member completes the right courses for their role, with automatic tracking of completions, expiry dates, and retraining requirements. User management ties directly into a role-based permission system, so the right people have access to the right processes — and regulators can see exactly who approved what, when, and why.  

The result is end-to-end compliance visibility: a medtech company can manage their ISO 13485 documentation, their EU AI Act high-risk AI obligations, and their ISO 9001 quality processes in one place — with staff training status, document approval workflows, and audit readiness all connected. When an auditor asks for evidence, everything is already organized, version-controlled, and traceable to the individuals who own it.

The system is currently in advanced development. We are not building another enterprise compliance dinosaur — we are building something that a regulated-industry startup or mid-sized company can actually use from day one.

Why This Matters Now

The EU AI Act applies not only to European companies. Any organisation serving the European market with AI systems must comply — regardless of where the company is headquartered. This includes US and Asian technology companies that have so far operated without comparable regulatory oversight.

We are building AI-QMS because we have lived in regulated environments — medical devices, pharmaceutical software, clinical AI — and we know what functional compliance infrastructure actually requires.

Interested in early access or partnership discussions? Contact us at robert.hoffmeister@goodly-technologies.com

Goodly Technologies GmbH · Baierbrunn · goodly-technologies.com